These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 21912455)

  • 21. [Randomized clinical trial of percutaneous radiofrequency ablation plus absolute ethanol injection compared with radiofrequency ablation alone for small hepatocellular carcinoma].
    Chen MS; Zhang YJ; Li JQ; Liang HH; Zhang YQ; Zheng Y
    Zhonghua Zhong Liu Za Zhi; 2005 Oct; 27(10):623-5. PubMed ID: 16438875
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Percutaneous ablation procedures in cirrhotic patients with hepatocellular carcinoma submitted to liver transplantation: Assessment of efficacy at explant analysis and of safety for tumor recurrence.
    Pompili M; Mirante VG; Rondinara G; Fassati LR; Piscaglia F; Agnes S; Covino M; Ravaioli M; Fagiuoli S; Gasbarrini G; Rapaccini GL
    Liver Transpl; 2005 Sep; 11(9):1117-26. PubMed ID: 16123960
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Systematic review of radiofrequency ablation versus percutaneous ethanol injection for small hepatocellular carcinoma up to 3 cm.
    Shen A; Zhang H; Tang C; Chen Y; Wang Y; Zhang C; Wu Z
    J Gastroenterol Hepatol; 2013 May; 28(5):793-800. PubMed ID: 23432154
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Percutaneous ethanol injection for small hepatocellular carcinoma: therapeutic efficacy based on 20-year observation.
    Ebara M; Okabe S; Kita K; Sugiura N; Fukuda H; Yoshikawa M; Kondo F; Saisho H
    J Hepatol; 2005 Sep; 43(3):458-64. PubMed ID: 16005538
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Ethanol versus radiofrequency ablation for the treatment of small hepatocellular carcinoma in patients with cirrhosis: a retrospective study of efficacy and cost.
    Seror O; N'Kontchou G; Tin Tin Htar M; Durand-Zaleski I; Trinchet JC; Sellier N; Beaugrand M
    Gastroenterol Clin Biol; 2006 Nov; 30(11):1265-73. PubMed ID: 17185968
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Randomised controlled trial comparing percutaneous radiofrequency thermal ablation, percutaneous ethanol injection, and percutaneous acetic acid injection to treat hepatocellular carcinoma of 3 cm or less.
    Lin SM; Lin CJ; Lin CC; Hsu CW; Chen YC
    Gut; 2005 Aug; 54(8):1151-6. PubMed ID: 16009687
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Clinical outcomes of radiofrequency ablation, percutaneous alcohol and acetic acid injection for hepatocelullar carcinoma: a meta-analysis.
    Germani G; Pleguezuelo M; Gurusamy K; Meyer T; Isgrò G; Burroughs AK
    J Hepatol; 2010 Mar; 52(3):380-8. PubMed ID: 20149473
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Percutaneous ethanol injection for hepatocellular carcinoma: 20-year outcome and prognostic factors.
    Shiina S; Tateishi R; Imamura M; Teratani T; Koike Y; Sato S; Obi S; Kanai F; Kato N; Yoshida H; Omata M; Koike K
    Liver Int; 2012 Oct; 32(9):1434-42. PubMed ID: 22712520
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Local ablation for hepatocellular carcinoma.
    Boyvat F
    Exp Clin Transplant; 2014 Mar; 12 Suppl 1():55-9. PubMed ID: 24635794
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prognosis of small hepatocellular carcinoma after laparoscopic ethanol injection.
    Kawamoto C; Ido K; Isoda N; Nagamine N; Hozumi M; Ono K; Nakazawa Y; Sato Y; Kimura K
    Gastrointest Endosc; 1999 Aug; 50(2):214-20. PubMed ID: 10425415
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prognosis of hepatocellular carcinoma with no tumor stain treated by percutaneous ethanol injection.
    Ueno H; Okada S; Okusaka T; Ikeda M; Tanaka N; Sakamoto M; Yoshimori M
    Hepatogastroenterology; 2001; 48(41):1430-4. PubMed ID: 11677980
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Treatment of small hepatocellular carcinoma with percutaneous ethanol injection: a validated prognostic model.
    Orlando A; D'Antoni A; Cammà C; Albanese M; Livraghi T; Torzilli G; Virdone R; Sciarrino E; Simonetti RG; Maringhini A; Pagliaro L; Cottone M
    Am J Gastroenterol; 2000 Oct; 95(10):2921-7. PubMed ID: 11051369
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Combining radiofrequency ablation and ethanol injection may achieve comparable long-term outcomes in larger hepatocellular carcinoma (3.1-4 cm) and in high-risk locations.
    Lin JW; Lin CC; Chen WT; Lin SM
    Kaohsiung J Med Sci; 2014 Aug; 30(8):396-401. PubMed ID: 25002377
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Treatment of small hepatocellular carcinoma in cirrhotic patients: a cohort study comparing surgical resection and percutaneous ethanol injection.
    Castells A; Bruix J; Bru C; Fuster J; Vilana R; Navasa M; Ayuso C; Boix L; Visa J; Rodés J
    Hepatology; 1993 Nov; 18(5):1121-6. PubMed ID: 8225217
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Combined percutaneous radiofrequency ablation and ethanol injection versus hepatic resection for 2.1-5.0 cm solitary hepatocellular carcinoma: a retrospective comparative multicentre study.
    Chen S; Peng Z; Lin M; Chen Z; Hu W; Xie X; Liu L; Qian G; Peng B; Li B; Kuang M
    Eur Radiol; 2018 Sep; 28(9):3651-3660. PubMed ID: 29600474
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Risk factors for intrahepatic recurrence of hepatocellular carcinoma in cirrhotic patients treated by percutaneous ethanol injection.
    Pompili M; Rapaccini GL; de Luca F; Caturelli E; Astone A; Siena DA; Villani MR; Grattagliano A; Cedrone A; Gasbarrini G
    Cancer; 1997 Apr; 79(8):1501-8. PubMed ID: 9118030
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A randomized controlled trial of radiofrequency ablation with ethanol injection for small hepatocellular carcinoma.
    Shiina S; Teratani T; Obi S; Sato S; Tateishi R; Fujishima T; Ishikawa T; Koike Y; Yoshida H; Kawabe T; Omata M
    Gastroenterology; 2005 Jul; 129(1):122-30. PubMed ID: 16012942
    [TBL] [Abstract][Full Text] [Related]  

  • 38. m-RECIST at 1 month and Child A are survival predictors after percutaneous ethanol injection of hepatocellular carcinoma.
    Silva MF; Carrilho FJ; Paranaguá-Vezozzo DC; Campos LT; Nacif LS; Diniz MA; Farias AQ; Alves VA; D'Alburquerque LA; Ono SK
    Ann Hepatol; 2014; 13(6):796-802. PubMed ID: 25332266
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Management of people with early- or very early-stage hepatocellular carcinoma: an attempted network meta-analysis.
    Majumdar A; Roccarina D; Thorburn D; Davidson BR; Tsochatzis E; Gurusamy KS
    Cochrane Database Syst Rev; 2017 Mar; 3(3):CD011650. PubMed ID: 28351116
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Intraoperative US-guided large volume ethanol injection for hepatocellular carcinoma greater than 4 cm.
    Mondragón-Sánchez R; Garduño-López AL; Gómez-Gómez E; Frias-Mendivil M; Mondragón-Sánchez A; Bernal-Maldonado R
    Ann Hepatol; 2005; 4(3):200-3. PubMed ID: 16177660
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.